Haematologica Reports 2005; 1(issue 8): 7-10[prev][index][next]

Deferasirox (ICL670): from bench to bedside
Alberti D
Clinical Program Leader, Novartis Pharma, Varese, Italy

This document accompanies the presentation by Dr Daniele Alberti, Clinical Program Leader, Novartis Pharma.
The presentation provides an overview of the drug development process and refers, by way of illustration, to a case history of a Novartis compound currently completing clinical development. [>Read full article in PDF]